Advertisement

Neurosurgical Review

, Volume 41, Issue 1, pp 323–331 | Cite as

Olfactory neuroblastoma: a single-center experience

  • Marton KönigEmail author
  • Terje Osnes
  • Peter Jebsen
  • Jan Folkvard Evensen
  • Torstein R. Meling
Original Article

Abstract

Olfactory neuroblastoma (ONB) is a potentially curable disease, despite being an aggressive malignancy with a poor natural history. Our goal was to evaluate management outcomes for patients with ONB treated at our institution. Our prospective database for brain tumors and the pathology registry of head and neck cancers at Oslo University Hospital were searched to identify all patients treated for ONB between 1998 and 2016. Variables extracted from these databases, supplemented by retrospective chart reviews, underwent thorough analysis. All cases were formally re-examined by a dedicated head and neck pathologist. Twenty patients were identified. Follow-up was 100%. Mean follow-up was 81.5 months for the entire cohort and 120.3 months for patients with no evidence of disease. Fourteen patients underwent treatment of choice including craniofacial resection (CFR) with or without radiotherapy (XRT). Six patients could only receive less extensive treatment; three patients underwent lateral rhinotomy (LR) with or without XRT after being deemed medically unsuitable for CFR, while another three patients received only supportive, non-surgical treatment (due to positive lymph node status in two and to extensive tumor size in one case). Overall and disease-specific survival rates were 100% after 10 years of follow-up when negative surgical margins were achieved by CFR. Positive margins were associated with poorer outcome with no patients surviving longer than 44 months. Long-term survival was also achieved in two cases among patients not eligible for CFR: one case after radical LR and one case after radio-chemotherapy. Advanced disease at presentation (tumor size ≥40 mm, Kadish grades C and D, or TNM IVa and IVb) and positive surgical margins were correlated to significantly dismal survival. Our study suggests that CFR with or without adjuvant XRT is safe and leads to excellent long-time overall and disease-specific survival. Negative surgical margins, tumor size <40 mm, Kadish stage A/B, and TNM stages I-III are independent prognostic predictors of outcome.

Keywords

Olfactory neuroblastoma Craniofacial resection Esthesioneuroblastoma Multidisciplinary approach Multimodal treatment Survival 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Ethical approval

This study was approved by the data protection official at OUH (ePhorte 2015-5042). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study does not contain any studies with animals performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

References

  1. 1.
    Berger L, Luc H, Richard RL (1924) Esthesioneuroepitheliome olfactif. Bull cancer (Paris) 13:1410–1421Google Scholar
  2. 2.
    Svane-Knudsen V et al (1998) Cancer of the nasal cavity and paranasal sinuses: a series of 115 patients. Rhinology 36(1):12–14PubMedGoogle Scholar
  3. 3.
    Morita A et al (1993) Esthesioneuroblastoma: prognosis and management. Neurosurgery 32(5):706–714 discussion 714-5 CrossRefPubMedGoogle Scholar
  4. 4.
    Bradley PJ, Jones NS, Robertson I (2003) Diagnosis and management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surg 11(2):112–118CrossRefPubMedGoogle Scholar
  5. 5.
    Lund VJ et al (2003) Olfactory neuroblastoma: past, present, and future? Laryngoscope 113(3):502–507CrossRefPubMedGoogle Scholar
  6. 6.
    Song CM et al (2012) Treatment modalities and outcomes of olfactory neuroblastoma. Laryngoscope 122(11):2389–2395CrossRefPubMedGoogle Scholar
  7. 7.
    Kadish S, Goodman M, Wang CC (1976) Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 37(3):1571–1576CrossRefPubMedGoogle Scholar
  8. 8.
    Bachar G et al (2008) Esthesioneuroblastoma: the Princess Margaret Hospital experience. Head Neck 30(12):1607–1614CrossRefPubMedGoogle Scholar
  9. 9.
    Dulguerov P, Allal AS, Calcaterra TC (2001) Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2(11):683–690CrossRefPubMedGoogle Scholar
  10. 10.
    Miyamoto RC et al (2000) Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis. Laryngoscope 110(8):1262–1265CrossRefPubMedGoogle Scholar
  11. 11.
    Ingeholm P et al (2002) Esthesioneuroblastoma: a Danish clinicopathological study of 40 consecutive cases. APMIS 110(9):639–645CrossRefPubMedGoogle Scholar
  12. 12.
    Bell D et al (2015) Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol 9(1):51–59CrossRefPubMedGoogle Scholar
  13. 13.
    Edge SB, Compton CC (2010) The american joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474Google Scholar
  14. 14.
    Dulguerov P, Calcaterra T (1992) Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 102(8):843–849CrossRefPubMedGoogle Scholar
  15. 15.
    Hyams VJ (1988) Tumors of the upper respiratory Tract and ear. In: Hyams VJ, Betsakis JG, Michaels L (eds) Atlas of tumor pathology, 2nd series. fascicle 25. Armed Forces Institute of pathology, WashingtonGoogle Scholar
  16. 16.
    Kairemo KJ et al (1998) Imaging of olfactory neuroblastoma—an analysis of 17 cases. Auris Nasus Larynx 25(2):173–179CrossRefPubMedGoogle Scholar
  17. 17.
    Pickuth D, Heywang-Kobrunner SH, Spielmann RP (1999) Computed tomography and magnetic resonance imaging features of olfactory neuroblastoma: an analysis of 22 cases. Clin Otolaryngol Allied Sci 24(5):457–461CrossRefPubMedGoogle Scholar
  18. 18.
    Derdeyn CP et al (1994) MRI of esthesioneuroblastoma. J Comput Assist Tomogr 18(1):16–21CrossRefPubMedGoogle Scholar
  19. 19.
    Broski SM et al (2012) The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma. J Nucl Med 53(8):1200–1206CrossRefPubMedGoogle Scholar
  20. 20.
    Fujioka T et al (2014) Long-term follow-up using 18F-FDG PET/CT for postoperative olfactory neuroblastoma. Nucl Med Commun 35(8):857–863PubMedGoogle Scholar
  21. 21.
    Elkhatib AH et al (2017) Role of 18 F-FDG PET/CT differentiating olfactory neuroblastoma from sinonasal undifferentiated carcinoma. Laryngoscope 127(2):321–324CrossRefPubMedGoogle Scholar
  22. 22.
    Faragalla H, Weinreb I (2009) Olfactory neuroblastoma: a review and update. Adv Anat Pathol 16(5):322–331CrossRefPubMedGoogle Scholar
  23. 23.
    Loy AH et al (2006) Esthesioneuroblastoma: continued follow-up of a single institution’s experience. Arch Otolaryngol Head Neck Surg 132(2):134–138CrossRefPubMedGoogle Scholar
  24. 24.
    Smee RI et al (2011) Retained role of surgery for olfactory neuroblastoma. Head Neck 33(10):1486–1492CrossRefPubMedGoogle Scholar
  25. 25.
    Nabili V et al (2011) Transnasal, transfacial, anterior skull base resection of olfactory neuroblastoma. Am J Otolaryngol 32(4):279–285CrossRefPubMedGoogle Scholar
  26. 26.
    Nichols AC et al (2008) Esthesioneuroblastoma: the Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. Skull Base 18(5):327–337CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Rimmer J et al (2014) Olfactory neuroblastoma: a 35-year experience and suggested follow-up protocol. Laryngoscope 124(7):1542–1549CrossRefPubMedGoogle Scholar
  28. 28.
    Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481CrossRefGoogle Scholar
  29. 29.
    Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50(3):163–170PubMedGoogle Scholar
  30. 30.
    Cox D (1972) Regression models and life tables. J R Stat Soc B 34:187–220Google Scholar
  31. 31.
    Fisher RA (1922) On the interpretation of Χ2 from contingency tables, and the calculation of P. J R Stat Soc 85(1):87–94CrossRefGoogle Scholar
  32. 32.
    Resto VA et al (2000) Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck 22(6):550–558CrossRefPubMedGoogle Scholar
  33. 33.
    Eich HT et al (2001) Radiotherapy of esthesioneuroblastoma. Int J Radiat Oncol Biol Phys 49(1):155–160CrossRefPubMedGoogle Scholar
  34. 34.
    Simon JH et al (2001) Esthesioneuroblastoma: the University of Iowa experience 1978-1998. Laryngoscope 111(3):488–493CrossRefPubMedGoogle Scholar
  35. 35.
    Gruber G et al (2002) Esthesioneuroblastoma: irradiation alone and surgery alone are not enough. Int J Radiat Oncol Biol Phys 54(2):486–491CrossRefPubMedGoogle Scholar
  36. 36.
    Hwang SK et al (2002) Olfactory neuroblastomas: survival rate and prognostic factor. J Neuro-Oncol 59(3):217–226CrossRefGoogle Scholar
  37. 37.
    Argiris A et al (2003) Esthesioneuroblastoma: the Northwestern University experience. Laryngoscope 113(1):155–160CrossRefPubMedGoogle Scholar
  38. 38.
    Devaiah AK et al (2003) Esthesioneuroblastoma: endoscopic nasal and anterior craniotomy resection. Laryngoscope 113(12):2086–2090CrossRefPubMedGoogle Scholar
  39. 39.
    Dias FL et al (2003) Patterns of failure and outcome in esthesioneuroblastoma. Arch Otolaryngol Head Neck Surg 129(11):1186–1192CrossRefPubMedGoogle Scholar
  40. 40.
    Poetker DM et al (2005) Endoscopic management of sinonasal tumors: a preliminary report. Am J Rhinol 19(3):307–315PubMedGoogle Scholar
  41. 41.
    Wang CC et al (2005) Transcranial resection of olfactory neuroblastoma. Skull Base 15(3):163–171 discussion 171 CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Yuen AP et al (2005) Endoscopic-assisted cranionasal resection of olfactory neuroblastoma. Head Neck 27(6):488–493CrossRefPubMedGoogle Scholar
  43. 43.
    Rastogi M et al (2006) Esthesioneuroblastoma treated with non-craniofacial resection surgery followed by combined chemotherapy and radiotherapy: an alternative approach in limited resources. Jpn J Clin Oncol 36(10):613–619CrossRefPubMedGoogle Scholar
  44. 44.
    Nakao K et al. (2007) Olfactory neuroblastoma: long-term clinical outcome at a single institute between 1979 and 2003. Acta Otolaryngol Suppl (559):113–117Google Scholar
  45. 45.
    Kim BJ et al (2008) Endoscopic versus traditional craniofacial resection for patients with sinonasal tumors involving the anterior skull base. Clin Exp Otorhinolaryngol 1(3):148–153CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Zafereo ME et al (2008) Esthesioneuroblastoma: 25-year experience at a single institution. Otolaryngol Head Neck Surg 138(4):452–458CrossRefPubMedGoogle Scholar
  47. 47.
    Ward PD et al (2009) Esthesioneuroblastoma: results and outcomes of a single institution’s experience. Skull Base 19(2):133–140CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Zhang M et al (2010) Diagnosis and management of esthesioneuroblastoma. ORL J Otorhinolaryngol Relat Spec 72(2):113–118CrossRefPubMedGoogle Scholar
  49. 49.
    Herr MW et al (2013) Orbital preservation in patients with esthesioneuroblastoma. J Neurol Surg B Skull Base 74(3):142–145CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Kaur G et al (2013) The prognostic implications of Hyam’s subtype for patients with Kadish stage C esthesioneuroblastoma. J Clin Neurosci 20(2):281–286CrossRefPubMedGoogle Scholar
  51. 51.
    El Kababri M et al (2014) Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review. J Pediatr Hematol Oncol 36(2):91–95CrossRefPubMedGoogle Scholar
  52. 52.
    Ow TJ et al (2014) Optimization of long-term outcomes for patients with esthesioneuroblastoma. Head Neck 36(4):524–530CrossRefPubMedGoogle Scholar
  53. 53.
    Petruzzelli GJ et al (2015) Multidisciplinary treatment of olfactory neuroblastoma: patterns of failure and management of recurrence. Am J Otolaryngol 36(4):547–553CrossRefPubMedGoogle Scholar
  54. 54.
    Herr MW et al (2014) Esthesioneuroblastoma: an update on the Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. J Neurol Surg B Skull Base 75(1):58–64PubMedGoogle Scholar
  55. 55.
    Tajudeen BA et al (2015) Esthesioneuroblastoma: an update on the UCLA experience, 2002-2013. J Neurol Surg B Skull Base 76(1):43–49CrossRefPubMedGoogle Scholar
  56. 56.
    Schmidt C et al (2016) Olfactory neuroblastoma: 14-year experience at an Australian tertiary centre and the role for longer-term surveillance. J Laryngol Otol:1–6Google Scholar
  57. 57.
    Lapierre A, Selmaji I, Samlali H, Brahmi T, Yossi S (2016) [Esthesioneuroblastoma: A single institution’s experience and general literature review]. Cancer radiotherapie: journal de la Societe francaise de radiotherapie oncologique 20(8):783–789. doi: 10.1016/j.canrad.2016.05.015
  58. 58.
    Yin ZZ et al (2016) Long-term outcomes of patients with esthesioneuroblastomas: a cohort from a single institution. Oral Oncol 53:48–53CrossRefPubMedGoogle Scholar
  59. 59.
    Casiano RR, Numa WA, Falquez AM (2001) Endoscopic resection of esthesioneuroblastoma. Am J Rhinol 15(4):271–279PubMedGoogle Scholar
  60. 60.
    Castelnuovo P et al (2007) Endonasal endoscopic resection and radiotherapy in olfactory neuroblastoma: our experience. Head Neck 29(9):845–850CrossRefPubMedGoogle Scholar
  61. 61.
    Dave SP, Bared A, Casiano RR (2007) Surgical outcomes and safety of transnasal endoscopic resection for anterior skull tumors. Otolaryngol Head Neck Surg 136(6):920–927CrossRefPubMedGoogle Scholar
  62. 62.
    Suriano M et al (2007) Endoscopic treatment of esthesioneuroblastoma: a minimally invasive approach combined with radiation therapy. Otolaryngol Head Neck Surg 136(1):104–107CrossRefPubMedGoogle Scholar
  63. 63.
    Folbe A et al (2009) Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study. Am J Rhinol Allergy 23(1):91–94CrossRefPubMedGoogle Scholar
  64. 64.
    Luong A, Citardi MJ, Batra PS (2010) Management of sinonasal malignant neoplasms: defining the role of endoscopy. Am J Rhinol Allergy 24(2):150–155CrossRefPubMedGoogle Scholar
  65. 65.
    Gallia GL et al (2012) Endoscopic resection of esthesioneuroblastoma. J Clin Neurosci 19(11):1478–1482CrossRefPubMedGoogle Scholar
  66. 66.
    De Bonnecaze G et al (2014) Long-term oncological outcome after endoscopic surgery for olfactory esthesioneuroblastoma. Acta Otolaryngol 134(12):1259–1264CrossRefPubMedGoogle Scholar
  67. 67.
    Zhang L et al (2016) Long-term prognostic analysis after endoscopic endonasal surgery for olfactory neuroblastoma: a retrospective study of 13 cases. PLoS One 11(11):e0166046CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Feng L et al (2015) Endoscopic endonasal resection of esthesioneuroblastoma: a single center experience of 24 patients. Clin Neurol Neurosurg 138:94–98CrossRefPubMedGoogle Scholar
  69. 69.
    Manthuruthil C et al (2016) Endoscopic endonasal management of olfactory neuroblastoma: a retrospective analysis of 10 patients with quality-of-life measures. World Neurosurg 90:1–5CrossRefPubMedGoogle Scholar
  70. 70.
    Wellman BJ et al (1999) Midline anterior craniofacial approach for malignancy: results of en bloc versus piecemeal resections. Skull Base Surg 9(1):41–46CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Devaiah AK, Andreoli MT (2009) Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients. Laryngoscope 119(7):1412–1416CrossRefPubMedGoogle Scholar
  72. 72.
    Fu TS et al (2016) Comparison of outcomes for open versus endoscopic approaches for olfactory neuroblastoma: a systematic review and individual participant data meta-analysis. Head Neck 38(Suppl 1):E2306–E2316CrossRefPubMedGoogle Scholar
  73. 73.
    De Bonnecaze G et al (2016) Long-term carcinologic results of advanced esthesioneuroblastoma: a systematic review. Eur Arch Otorhinolaryngol 273(1):21–26CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Marton König
    • 1
    • 2
    Email author
  • Terje Osnes
    • 2
    • 3
  • Peter Jebsen
    • 4
  • Jan Folkvard Evensen
    • 5
  • Torstein R. Meling
    • 1
    • 2
  1. 1.Department of NeurosurgeryOslo University Hospital—RikshospitaletOsloNorway
  2. 2.Institute of Clinical Medicine, Faculty of MedicineUniversity of OsloOsloNorway
  3. 3.Department of OtorhinolaryngologyOslo University Hospital—RikshospitaletOsloNorway
  4. 4.Department of PathologyOslo University Hospital—RikshospitaletOsloNorway
  5. 5.Department of OncologyOslo University Hospital—RadiumhospitaletOsloNorway

Personalised recommendations